News

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study shows that stroke-related deaths will rise among millennials as they get older. Researchers suggest that obesity and diabetes could be a cause.

We’re talking about how rehabilitation can help improve mobility and independence after a stroke.

Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.

Through the Havertys' generosity, the Center has been able to create a national model of care called the Cardiometabolic Center Alliance.

When Shannon Clarke, a 48-year-old, retired police officer, received a heart from Saint Luke’s Mid America Heart Institute, he had no idea just how transformational it would be. 

When John Murray was losing function in his hands and arms, it became difficult to play his music. He turned to the team at Saint Luke's Marion Bloch Neuroscience Institute to fix the issue threatening his independent lifestyle.

After he survived a sudden heart attack and found his way to Saint Luke's Mid America Heart Institute, Duane had a procedure that would not only save his life but get him back to truly living.